Lemocalm® Dry Cough

Dextromethorphan Hydrobromide, the active ingredient in Lemocalm® Dry Cough, is an antitussive presented as an oral formulation for oral use. It suppresses dry, non‑productive coughs in adults and children over a specified age, providing symptomatic relief without affecting breathing and can be used as directed by a healthcare professional.

GNH USA supplies Lemocalm® Dry Cough as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Dextromethorphan Hydrobromide is an antitussive that acts on the central cough centre to reduce the cough reflex. - Dry cough: reduces frequency and intensity of non‑productive coughs. - Cough due to upper respiratory tract infection: provides symptomatic relief. - Cough from throat irritation: suppresses the cough reflex without affecting breathing.

Common Side Effects: - Drowsiness: mild sedation may occur. - Nausea: occasional stomach upset. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Respiratory depression: unusually slow breathing, especially if overdosed. - Hallucinations or confusion: rare central nervous system effects.

Before using Lemocalm® Dry Cough, consider the following precautions: - Dosage adjustment: use lower dose in elderly or hepatic impairment. - Avoid alcohol: concurrent use may increase sedation. - Do not operate machinery: possible drowsiness may impair coordination. - Contraindicated in patients with known hypersensitivity to dextromethorphan. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Dextromethorphan Hydrobromide may interact with several medicines. Review the following interactions: Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - SSRIs and other serotonergic agents: increased risk of serotonin syndrome. - Linezolid: similar serotonergic risk. Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Antihistamines: additive sedative effect. - Other cough suppressants containing codeine: increased risk of respiratory depression.